Page last updated: 2024-08-26

sr141716 and methylatropine

sr141716 has been researched along with methylatropine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Niederhoffer, N; Schmid, K; Szabo, B1

Other Studies

1 other study(ies) available for sr141716 and methylatropine

ArticleYear
The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression.
    Naunyn-Schmiedeberg's archives of pharmacology, 2003, Volume: 367, Issue:5

    Topics: Animals; Atropine Derivatives; Benzoxazines; Bradycardia; Cannabinoids; Cardiovascular System; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Hypotension; Male; Medulla Oblongata; Microinjections; Morpholines; Naphthalenes; Norepinephrine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Sympathetic Fibers, Postganglionic; Sympathetic Nervous System

2003